PRODUCT LITERATURE

Comparison of the Lipid-Lowering Effects of Pitavastatin 4mg Versus Pravastatin 40mg in Adults With Primary Hyperlipidemia or Mixed (Combined)Dyslipidemia: A PhaseIV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial

---

Results froma Phase III, European, non-inferiority trial in elderly (age Z65 years) patients with primary hyperlipidemia or mixed(combined) dyslipidemia demonstrated significantly greater reductions in LDL-C for pitavastatin versus pravastatin across 3pair-wise dose comparisons (1mgvs10mg,2 mgvs20mg, and4mgvs40mg, respectively). The present study investigated whether pitavastatin 4mg is superior to pravastatin 40mg in LDL-Creductionin adults (18–80 years old)withprimary hyperlipidemia or mixed(combined)dyslipidemia.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Vitor

Specific Detail Info

Clin Ther. 2014;36:1211–1222

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment